big ideas for global investors Search
   Members       Sign-up       Newsfeeds        Companies        Stock Directories       Research       Video       Funding   

OTC Biotech Stock Alert: Bio-Matrix Scientific Group Inc. (OTC: BMSN) Trends up Technically Following Recent News on IND Application to FDA

Category: Investment

Visit: Bio-Matrix Scientific Group, Inc.

Point Roberts, WA - February 15, 2013 ( newswire) staff:, an investor research portal specializing in sector research for independent investors issues a trading alert for microcap biotech stock, Bio-Matrix Scientific Group Inc. (OTC:BMSN), currently trading at $0.136 on over 21 Million shares. The stock has trended up technically (see 5 day chart below) following news earlier this month of an IND filing application with the FDA.

On February 5 th, Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. (OTC:BMSN), announced filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company's HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia.

HemaXellerate I™ is a patient-specific composition of cells that have previously been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company, together with an internationally-renowned group of stem cell researchers, recently published the scientific basis for the HemaXellerate I™ product which may be found at

5 day chart Newswire

About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:

Bio-Matrix Scientific Group, Inc. (BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indications.

Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. (PINKSHEETS: BMSN), is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. To follow our development, visit us at

OTC Markets:

More info on BMSN:

As always, investors need to be aware of risks of investing in microcap OTC stocks.

About OTCBB:

About is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow on Twitter!/Investorideas

Follow on Facebook

Follow News on at

Sign up for the free investor news and stock alerts at

Become an Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…

Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:

800-665-0411 - Source -

Free News Alerts

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner


Investor Ideas © 2000 - 2015®, ECON


login | logout | about us | contact | disclaimer / disclosure |
partners / links | job search | privacy policy |
advertise | trade | sitemap |